TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 206 filers reported holding TURNING POINT THERAPEUTICS I in Q1 2021. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $3,257,000 | -34.4% | 121,286 | +16.4% | 0.00% | -25.0% |
| Q4 2021 | $4,968,000 | -31.7% | 104,156 | -4.8% | 0.00% | -42.9% |
| Q3 2021 | $7,269,000 | -27.8% | 109,418 | -15.2% | 0.01% | -22.2% |
| Q2 2021 | $10,066,000 | -58.4% | 129,019 | -49.6% | 0.01% | -60.9% |
| Q1 2021 | $24,208,000 | +110.7% | 255,929 | +171.4% | 0.02% | +130.0% |
| Q4 2020 | $11,491,000 | +4874.5% | 94,301 | +2537.1% | 0.01% | – |
| Q2 2020 | $231,000 | -12.5% | 3,576 | -15.7% | 0.00% | – |
| Q4 2019 | $264,000 | – | 4,241 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,392,297 | $291,501,000 | 6.94% |
| Burrage Capital Management LLC | 72,484 | $8,832,000 | 6.73% |
| MPM BioImpact LLC | 617,372 | $75,226,000 | 6.50% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 113,541 | $13,816,000 | 3.77% |
| Orbimed Advisors | 2,745,327 | $334,518,000 | 2.93% |
| SECTORAL ASSET MANAGEMENT INC | 257,379 | $31,362,000 | 2.21% |
| Parkman Healthcare Partners LLC | 59,377 | $7,235,000 | 1.85% |
| Nicholas Investment Partners, LP | 183,676 | $22,381,000 | 1.73% |
| EMERALD ADVISERS, LLC | 357,038 | $43,505,000 | 1.44% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 336,173 | $40,963,000 | 1.42% |